Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Opdivo (nivolumab) — Bristol-Myers Squibb Pharma EEIG
European Medicines Agency authorises Opdivo (nivolumab) for multiple cancer indications, including melanoma, non-small cell lung cancer, ren…
-
EMA approval · 2026-07-01EMA Authorised: Keytruda (pembrolizumab) — Merck Sharp & Dohme B.V.
EMA authorises Keytruda (pembrolizumab) for multiple cancer indications, including melanoma, Hodgkin disease, renal cell carcinoma, non-smal…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Ipilimumab for Head and Neck Cancer Patients [Phase 1]
A Phase 1 clinical trial evaluating ipilimumab for squamous cell carcinoma of the head and neck is currently active but not recruiting.
-
EMA approval · 2026-04-22EMA Authorised: Keytruda (pembrolizumab) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Keytruda (pembrolizumab) for multiple cancer indications, including melanoma, Hodgkin lymphoma, ren…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Pilot Study of Imatinib Cetuximab Combo for H & N Cancer [EARLY_Phase 1]
A pilot early-phase trial evaluating the combination of imatinib and cetuximab for head and neck cancer; the study is currently active but n…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab [Phase 1]
A Phase 1 clinical trial evaluating how BI 765063 and BI 770371 are taken up in tumors of patients with advanced cancers who are receiving e…
-
CLINICAL_TRIALS other · 2026-04-20Clinical Trial Update: A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors [Phase 1]
Clinical trial update for PF-08046054/SGN-PDL1V in advanced solid tumors shows a Phase 1 study is currently recruiting across multiple indic…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors [Phase 2]
Phase 2 clinical trial evaluating intraoperative imaging with indocyanine green for margin assessment in head and neck squamous cell carcino…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 [Phase 2]
Phase 2 platform trial GALAXIES H&N-202 evaluating novel immunotherapy combinations as first-line treatment for PD-L1 positive recurrent/met…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for PF-08046052/SGN-EGFRd2 in advanced solid tumors, including colorectal cancer, non-small cell lung cancer, …
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Nutrition and Life QUality Patients With Head and Neck Cancers [NA]
This entry notes the completion of a clinical trial evaluating nutrition and quality of life in patients with head and neck squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer [Phase 1]
Phase 1 safety study evaluating afatinib in combination with postoperative radiation therapy for squamous cell carcinoma of the head and nec…
-
EMA approval · 2026-03-18EMA Authorised: Opdivo (nivolumab) — Bristol-Myers Squibb Pharma EEIG
EMA authorised Opdivo (nivolumab) for multiple cancer indications, including melanoma, Hodgkin lymphoma, renal cell carcinoma, non-small cel…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in combination with pembrolizumab for metastatic solid tumors has completed, enrolling patients with me…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer [Phase 2]
Randomized Phase II study evaluated DCE-MRI–guided dose escalation for poor-prognosis squamous cell carcinoma of the head and neck. The tria…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. [Phase 1]
Phase 1 study of PF-07826390 in cancer patients, including non-small cell lung cancer, was terminated; the trial evaluated different doses o…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) [Phase 3]
Phase III XRAY VISION trial evaluating Xevinapant with radiotherapy in resected locally advanced head and neck squamous cell carcinoma in ci…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy [NA]
A University of Virginia-sponsored clinical trial is recruiting to evaluate stereotactic MRI-guided focused ultrasound mesencephalotomy for …
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab for relapsed, locally recurrent squamous cell carcinoma of the head and neck; the study is…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of DM005 in Patients With Advanced Solid Tumors [Phase 1]
DM005 is being studied in a Phase 1 trial for patients with advanced solid tumors, including non-small-cell lung cancer and head and neck sq…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
A clinical trial update describing a multi-omic assessment of squamous cell cancers receiving systemic therapy; currently active but not rec…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 3]
A Phase 3 clinical trial is evaluating de-escalation surgery after immunotherapy for locally advanced head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck [Phase 1]
Phase 1 study evaluating pembrolizumab in combination with chemoradiotherapy for squamous cell carcinoma of the head and neck; the trial was…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Takeda's TAK-186 (MVC-101) was studied in a Phase 1/2 trial for adults with advanced or metastatic cancers including squamous cell carcinoma…